Fingerprint
Dive into the research topics of 'Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis
Alessandro Loglio, Peter Ferenci, Sara Colonia Uceda Renteria, Christine Y.L. Tham, Caroline Scholtes, Heidemarie Holzmann, Florian van Bömmel, Marta Borghi, Riccardo Perbellini, Alessandro Rimondi, Elisa Farina, Elena Trombetta, Maria Manunta, Laura Porretti, Daniele Prati, Ferruccio Ceriotti, Fabien Zoulim, Antonio Bertoletti, Pietro Lampertico
Research output: Contribution to journal › Article › peer-review